Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBrady Regulatory News (BRY)

  • There is currently no data for BRY

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Cancellation from Trading on AIM

5 Dec 2019 08:23

RNS Number : 7957V
Brady plc
05 December 2019
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION

 

5 December 2019

Brady plc 

("Brady" or the "Company")

 

Cancellation from Trading on AIM

Further to the announcement by Hanover Acquisition Limited ("Hanover") today confirming that Hanover has acquired, or agreed to acquire, in excess of 75 per cent. of the Company's ordinary shares of 1p each ("Ordinary Shares") pursuant to Hanover's recommended mandatory final offer for the Company as announced on 18 November 2019 (the "Mandatory Offer"), the Company announces that, in line with the intentions set out in Hanover's original offer document dated 17 October 2019, it has informed the London Stock Exchange that it wishes to cancel the admission to trading of Brady's Ordinary Shares on AIM (the "Cancellation").

 

Cancellation is expected to take effect from 7.00 a.m. on 8 January 2020, being 20 business days from the date of this announcement. Following Cancellation, Hanover will seek to re-register Brady as a private limited company.

 

There will be no trading facility put in place to enable shareholders to trade their Brady Ordinary Shares following Cancellation and the Cancellation will significantly reduce the liquidity and marketability of the Brady Ordinary Shares not acquired by Hanover. The Brady Board therefore recommends those Brady shareholders who have not already accepted the Mandatory Offer to accept the Mandatory Offer as soon as possible. The procedure for acceptance of the Mandatory Offer is set out in the Mandatory Offer document published on 20 November 2019 (the "Mandatory Offer Document").

Actions to be taken

 

Shareholders are encouraged to accept the Mandatory Offer as soon as possible and no later than 3.00 p.m. (London time) on 5 December 2019.

 

The full terms and conditions and the procedures for acceptance of the Mandatory Offer are set out in full in the Mandatory Offer Document and in the revised form of acceptance published by Hanover on 20 November 2019 (the "Revised Form of Acceptance"). Terms and expressions used in this announcement shall, unless defined herein or unless the context otherwise requires, have the same meanings as given to them in the Mandatory Offer Document, a copy of which is available on Hanover's website at www.hanoverinvestors.com and Brady's website at www.bradyplc.com.

If you have any questions about acceptance of the Mandatory Offer, please call Computershare between 8.30 a.m. and 5.30 p.m. (London time) Monday to Friday (except public holidays in England and Wales) on 0370 702 0000 (if calling from within the UK) or +44 (0)370 702 0000 (if calling from outside the UK). Please note that Computershare cannot provide any financial, legal or tax advice and calls may be recorded and monitored for security and training purposes.

 

Further copies of the Mandatory Offer Document and the revised form of acceptance may be obtained by contacting Carmen Carey at Centennium House, 100 Lower Thames Street, London, EC3R 6DL or by telephoning 020 3301 1200 or by emailing Brady marketing@bradyplc.com.

 

For further information please contact:

 

Brady plc

Carmen Carey, Chief Executive Officer

Martin Thorneycroft, Chief Financial Officer

 

Telephone: +44(0)1223 479479

 

Cenkos Securities plc - NOMAD and broker

 Ben Jeynes / Cameron MacRitchie

 

 

Telephone: +44 (0)20 7397 8900

Newgate Communications

Bob Huxford / Ian Silvera/ Megan Kovach

 

Telephone: +44 (0)20 7382 4730

 

 

This announcement is not intended to and does not constitute, or form part of, any offer to sell or subscribe for or an invitation to purchase or subscribe for any securities or the solicitation of any vote or approval in any jurisdiction pursuant to the Mandatory Offer or otherwise, nor shall there be any sale, issuance or transfer of securities of Brady in any jurisdiction in contravention of applicable law. This announcement does not constitute a prospectus or equivalent document.

 

Any acceptance or other response to the Mandatory Offer should only be made on the basis of the information contained in the Mandatory Offer Document and the Revised Form of Acceptance. Brady Shareholders who have not yet accepted the Mandatory Offer are advised to read the formal documentation in relation to the Mandatory Offer carefully.

 

Panmure Gordon (UK) Limited, which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting exclusively for Hanover and no-one else in connection with the Mandatory Offer and other matters referred to in this announcement and will not be responsible to anyone other than Hanover for providing the protections afforded to clients of Panmure Gordon nor for providing advice in relation to the Mandatory Offer, this announcement or any other matter referred to herein. Neither Panmure Gordon nor any of its subsidiaries, branches or affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Panmure Gordon in connection with this announcement, any statement contained herein or otherwise.

 

Cenkos Securities plc ("Cenkos"), which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting exclusively as financial adviser to Brady and no-one else in connection with the Offer and other matters referred to in this announcement. In connection with these matters, Cenkos, its affiliates and their respective directors, officers, employees and agents will not regard any other person as their client, nor will they be responsible to anyone other than Brady for providing the protections afforded to the clients of Cenkos nor for providing advice in relation to the matters referred to in this announcement.

 

Overseas jurisdictions

 

The availability of the Mandatory Offer or the release, publication or distribution of this announcement in or into, jurisdictions other than the United Kingdom may be restricted by law and therefore persons into whose possession this announcement comes who are not resident in the United Kingdom should inform themselves about, and observe, any applicable restrictions. Brady Shareholders who are in any doubt regarding such matters should consult an appropriate independent adviser in the relevant jurisdiction without delay. Any failure to comply with such restrictions may constitute a violation of the securities laws of any such jurisdiction.

 

This announcement has been prepared for the purposes of complying with English law and the Code and the information disclosed may not be the same as that which would have been disclosed if this announcement had been prepared in accordance with the laws of jurisdictions outside the United Kingdom. The statements contained in this announcement are not to be construed as legal, business, financial or tax advice.

 

Notice to US shareholders of Brady Shares

 

It may be difficult for US holders of Brady securities to enforce their rights under and any claim arising out of the US federal securities laws, since Hanover and Brady are located outside the United States, and some or all of their officers and directors may be resident outside the United States. US Brady Shareholders may not be able to sue a non-US company or its officers or directors in a non-US court for violations of the US securities laws. Further, it may be difficult to compel a non-US company and its affiliates to subject themselves to a US court's judgement and a US court may lack jurisdiction over such persons.

 

The Mandatory Offer will be made for securities of an English company and is being made in the United States in compliance with, and in reliance on, Section 14(e) of the United States Securities Exchange Act of 1934 (the "Exchange Act"), Regulation 14E thereunder and the exemption therefrom provided by Rule 14d-1(d) under the Exchange Act. The Mandatory Offer is being made in the United States by Hanover and no one else. The Mandatory Offer is subject to disclosure and procedural requirements of the United Kingdom which are different from those in the United States. In addition, US investors should be aware that this announcement has been prepared in accordance with English law and the Code and applicable disclosure requirements, format and style thereunder, all of which differ from those in the United States. Furthermore, the payment and settlement procedures with respect to the Mandatory Offer will comply with the relevant UK rules, which differ from US payment and settlement procedures. Neither the United States Securities Exchange Commission, nor any securities commission of any state or other jurisdiction of the United States, has approved the Mandatory Offer or passed upon the adequacy or completeness of this announcement.

 

The receipt of cash pursuant to the Mandatory Offer may have tax consequences in the United States and under other applicable tax laws and such consequences, if any, are not described herein. US Brady Shareholders are urged to consult with their own legal, tax and financial advisors in connection with making a decision regarding the Mandatory Offer.

 

To the extent permitted by applicable law, in accordance with, and to the extent permitted by, the Code and normal UK market practice, Hanover or nominees or brokers of Hanover (acting as agents) or their respective affiliates may from time to time make certain purchases of, or arrangements to purchase, Brady Shares or other Brady securities outside the United States other than pursuant to the Mandatory Offer at any time prior to completion of the Mandatory Offer. These purchases may occur either in the open market at prevailing prices or in private transactions at negotiated prices. Any such purchases, or arrangements to purchase, will comply with all applicable requirements of the Code, the Listing Rules and Regulation 14E under the US Exchange Act including Rule 14e-5, to the extent applicable. In addition, in accordance with the Code, normal United Kingdom market practice and Rule 14e-5(b) of the Exchange Act, Panmure Gordon and Cenkos Securities plc will continue to act as connected exempt market maker or connected exempt principal trader in Brady Shares or other Brady securities on the London Stock Exchange. To the extent required to be disclosed in accordance with applicable regulatory requirements, information about any such purchases and activities, including without limitation, such purchases and activities by the connected exempt market maker or connected exempt principal trader, will be disclosed on a next day basis to the Panel and will be available from any Regulatory Information Service, including the Regulatory News Service on the London Stock Exchange website, www.londonstockexchange.com. To the extent that such information is required to be publicly disclosed in the United Kingdom in accordance with applicable regulatory requirements, this information will as applicable also be publicly disclosed in the United States.

 

Publication of this announcement

 

A copy of this announcement will be available subject to certain restrictions relating to persons resident in Restricted Jurisdictions on www.hanoverinvestors.com and wwww.bradyplc.com by no later than 12 noon on the business day following the date of this announcement. The contents of Hanover Investors' website and Brady's website are not incorporated into and do not form part of this announcement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCCKPDDFBDKQBK
Date   Source Headline
19th Dec 201912:52 pmRNSTR-1: Notification of Major Holdings
13th Dec 201912:55 pmRNSTR-1: Notification of Major Holdings
9th Dec 20199:17 amRNSDirectorate Changes
6th Dec 20197:00 amRNSOffer Update
5th Dec 20195:30 pmRNSBrady
5th Dec 20198:23 amRNSCancellation from Trading on AIM
5th Dec 20197:00 amRNSLevel of acceptances
4th Dec 20194:33 pmRNSTR-1: Notification of Major Holdings
21st Nov 20194:45 pmRNSDirectorate Changes
21st Nov 20194:40 pmRNSDirectorate Changes
21st Nov 20192:35 pmRNSNew £5.0 million Loan Agreement
21st Nov 20199:46 amRNSForm 8.5 (EPT/NON-RI)
21st Nov 20199:08 amRNSForm 8.5 (EPT/RI)
21st Nov 20197:00 amRNSTR-1: Notification of Major Holdings
20th Nov 20194:22 pmRNSMandatory Final Cash Offer
20th Nov 20199:51 amRNSForm 8.5 (EPT/NON-RI)
19th Nov 20193:30 pmRNSForm 8.3 - Brady Plc
19th Nov 20193:03 pmRNSTR-1: Notification of Major Holdings
19th Nov 20192:55 pmRNSTR-1: Notification of Major Holdings
19th Nov 201911:18 amGNWForm 8.3 - Brady plc
19th Nov 20199:25 amRNSForm 8.5 (EPT/NON-RI)
19th Nov 20197:00 amRNSRecommended Mandatory Final Cash Offer
18th Nov 20195:09 pmRNSForm 8 (DD) - Hanover Acquisition Limited
18th Nov 20194:34 pmRNSTR-1: Notification of Major Holdings
18th Nov 20193:08 pmRNSForm 8.3 - Brady Plc
18th Nov 20192:05 pmRNSSecond Price Monitoring Extn
18th Nov 20192:00 pmRNSPrice Monitoring Extension
18th Nov 20191:08 pmRNSRecommended Mandatory Final Cash Offer
18th Nov 201910:37 amRNSRecommended Revised Final Cash Offer
18th Nov 20199:00 amRNSStatement re Possible Offer
18th Nov 20197:00 amRNSFirst Closing Date and Extension to Offer
15th Nov 20191:05 pmPRNForm 8.3 - Brady Plc
15th Nov 20198:54 amRNSForm 8.5 (EPT/NON-RI)
14th Nov 201911:17 amPRNForm 8.3 - Brady Plc
13th Nov 20194:40 pmRNSNew £3.0 million Loan Agreement
12th Nov 20191:18 pmRNSForm 8.5 (EPT/NON-RI)
11th Nov 201911:05 amRNSLoan Agreement
8th Nov 20199:09 amRNSForm 8.5 (EPT/NON-RI)
5th Nov 20193:19 pmBUSForm 8.3 - Brady Plc
5th Nov 20193:18 pmBUSForm 8.3 - Brady Plc
1st Nov 201910:16 amBUSForm 8.3 - Brady Plc
31st Oct 20193:21 pmBUSForm 8.3 - Brady Plc
30th Oct 20193:03 pmBUSFORM 8.3 - BRADY PLC
30th Oct 20192:47 pmBUSForm 8.3 - Brady Plc
30th Oct 20199:55 amRNSForm 8.5 (EPT/NON-RI)
29th Oct 20193:15 pmRNSForm 8.3 - Brady PLC
28th Oct 20193:15 pmRNSForm 8.3 - Brady PLC
28th Oct 20193:01 pmRNSTR-1: Notification of Major Holdings
28th Oct 201910:45 amRNSForm 8.5 (EPT/NON-RI)
25th Oct 20193:20 pmRNSForm 8.3 - Brady PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.